STONKWHISPER
← Back to Intel
Insider ActivityOTLK

Sukhtian Faisal Ghiath, Director at Outlook Therapeutics, Inc., bought $50K of OTLK

Updated Jun 10, 2026
Sukhtian Faisal Ghiath Director
Outlook Therapeutics, Inc. · $OTLK
$50K Total Value
122,174 Shares Traded
$0.4093 Price / Share
125,574 Shares Owned After
2026-05-27 Filing Date

Transaction Details

InsiderSukhtian Faisal Ghiath
TitleDirector
CompanyOutlook Therapeutics, Inc.
TickerOTLK
Transaction TypePurchase
Transaction Date2026-05-27
Shares Traded122,174
Price Per Share$0.4093
Total Value$50K
Filed Date2026-05-27
Accession Number0001649989-26-000004

Ownership Context

Shares Owned After Transaction125,574
Ownership TypeDirect

SEC Filing

↗ View Original SEC Filing

Accession: 0001649989-26-000004

Other Insider Trades — OTLK

Full Ticker Profile

View all insider trades, dark pool activity, congressional filings, and the Whisper Score for OTLK — Outlook Therapeutics, Inc. →

Track OTLK insider activity in real time on The Wire →

Get alerts when Sukhtian Faisal Ghiath files new trades — Go Pro →

Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.

Last updated: June 10, 2026 at 07:06 UTC

Want real-time data? Access The Wire for live sentiment tracking.